Regeneron Cash from 2010 to 2024

REGN Stock  USD 985.02  4.45  0.45%   
Regeneron Pharmaceuticals Cash yearly trend continues to be very stable with very little volatility. Cash is likely to grow to about 2.9 B this year. Cash is the total amount of money in the form of currency that Regeneron Pharmaceuticals has in its possession. This includes all bills, coins, and funds in bank accounts. View All Fundamentals
 
Cash  
First Reported
1990-12-31
Previous Quarter
2.7 B
Current Value
2.6 B
Quarterly Volatility
889.3 M
 
Oil Shock
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Regeneron Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Regeneron main balance sheet or income statement drivers, such as Depreciation And Amortization of 442.1 M, Interest Expense of 76.7 M or Total Revenue of 13.8 B, as well as many exotic indicators such as Price To Sales Ratio of 6.79, Dividend Yield of 0.0 or PTB Ratio of 5.22. Regeneron financial statements analysis is a perfect complement when working with Regeneron Pharmaceuticals Valuation or Volatility modules.
  
This module can also supplement Regeneron Pharmaceuticals' financial leverage analysis and stock options assessment as well as various Regeneron Pharmaceuticals Technical models . Check out the analysis of Regeneron Pharmaceuticals Correlation against competitors.
To learn how to invest in Regeneron Stock, please use our How to Invest in Regeneron Pharmaceuticals guide.

Latest Regeneron Pharmaceuticals' Cash Growth Pattern

Below is the plot of the Cash of Regeneron Pharmaceuticals over the last few years. Cash refers to the most liquid asset of Regeneron Pharmaceuticals, which is listed under current asset account on Regeneron Pharmaceuticals balance sheet and usually includes currency, coins, checking accounts, and not deposited checks received from Regeneron Pharmaceuticals customers. The amounts must be unrestricted with restricted cash listed in a different Regeneron Pharmaceuticals account. It is the total amount of money in the form of currency that a company has in its possession. This includes all bills, coins, and funds in bank accounts. Regeneron Pharmaceuticals' Cash historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Regeneron Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
Cash10 Years Trend
Slightly volatile
   Cash   
       Timeline  

Regeneron Cash Regression Statistics

Arithmetic Mean1,396,283,400
Geometric Mean862,349,717
Coefficient Of Variation77.94
Mean Deviation945,762,160
Median812,733,000
Standard Deviation1,088,228,267
Sample Variance1184240.8T
Range3.1B
R-Value0.94
Mean Square Error137572.9T
R-Squared0.89
Slope229,836,300
Total Sum of Squares16579370.6T

Regeneron Cash History

20242.9 B
20232.7 B
20223.1 B
20212.9 B
20202.2 B
20191.6 B
20181.5 B

Other Fundumenentals of Regeneron Pharmaceuticals

Regeneron Pharmaceuticals Cash component correlations

About Regeneron Pharmaceuticals Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Regeneron Pharmaceuticals income statement, its balance sheet, and the statement of cash flows. Regeneron Pharmaceuticals investors use historical funamental indicators, such as Regeneron Pharmaceuticals's Cash, to determine how well the company is positioned to perform in the future. Although Regeneron Pharmaceuticals investors may use each financial statement separately, they are all related. The changes in Regeneron Pharmaceuticals's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Regeneron Pharmaceuticals's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Regeneron Pharmaceuticals Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Regeneron Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Cash2.7 B2.9 B
Cash And Short Term Investments10.8 B11.4 B
Change In Cash-381.6 M-362.5 M
Free Cash Flow3.7 B3.9 B
Begin Period Cash Flow3.1 B3.3 B
Other Cashflows From Financing Activities-700.6 M-665.6 M
Other Non Cash Items266.3 M279.6 M
Total Cash From Operating Activities4.6 B4.8 B
Total Cash From Financing Activities-1.8 B-1.7 B
End Period Cash Flow2.7 B2.9 B
Other Cashflows From Investing Activities-1.1 B-1.1 B
Total Cashflows From Investing Activities-3.4 B-3.2 B
Cash And Cash Equivalents Changes254.5 M245.4 M
Free Cash Flow Yield 0.04  0.04 
Operating Cash Flow Per Share 43.06  45.21 
Free Cash Flow Per Share 34.37  36.09 
Cash Per Share 101.64  106.72 
Capex To Operating Cash Flow(0.20)(0.19)
EV To Operating Cash Flow 20.39  21.41 
EV To Free Cash Flow 25.54  26.82 
Price To Operating Cash Flows Ratio 20.40  21.42 
Price To Free Cash Flows Ratio 25.55  26.83 
Cash Ratio 0.80  0.76 
Cash Conversion Cycle 554.48  582.20 
Operating Cash Flow Sales Ratio 0.35  0.37 
Free Cash Flow Operating Cash Flow Ratio 0.80  1.33 
Cash Flow Coverage Ratios 1.70  1.78 
Price Cash Flow Ratio 20.40  21.42 
Cash Flow To Debt Ratio 1.70  1.78 

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Regeneron Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Regeneron Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Regeneron Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Regeneron Pharmaceuticals Stock:
Check out the analysis of Regeneron Pharmaceuticals Correlation against competitors.
To learn how to invest in Regeneron Stock, please use our How to Invest in Regeneron Pharmaceuticals guide.
Note that the Regeneron Pharmaceuticals information on this page should be used as a complementary analysis to other Regeneron Pharmaceuticals' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.

Complementary Tools for Regeneron Stock analysis

When running Regeneron Pharmaceuticals' price analysis, check to measure Regeneron Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Regeneron Pharmaceuticals is operating at the current time. Most of Regeneron Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Regeneron Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Regeneron Pharmaceuticals' price. Additionally, you may evaluate how the addition of Regeneron Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Is Regeneron Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Regeneron Pharmaceuticals. If investors know Regeneron will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Regeneron Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.13)
Earnings Share
33.88
Revenue Per Share
122.574
Quarterly Revenue Growth
(0.01)
Return On Assets
0.0774
The market value of Regeneron Pharmaceuticals is measured differently than its book value, which is the value of Regeneron that is recorded on the company's balance sheet. Investors also form their own opinion of Regeneron Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Regeneron Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Regeneron Pharmaceuticals' market value can be influenced by many factors that don't directly affect Regeneron Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Regeneron Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Regeneron Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Regeneron Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.